Literature DB >> 26578749

Bidirectional expression of long ncRNA/protein-coding gene pairs in cancer.

Anne-Susann Albrecht, Ulf Andersson Ørom.   

Abstract

Bidirectional initiation of transcription by RNA polymerase II occurs prevalently at active promoters during protein-coding gene (PCG) expression. Upstream, antisense noncoding RNAs (ncRNAs) of differing lengths, stabilities and processings are being expressed from these promoters in concert with downstream, processive messenger RNA transcription. Although abundantly detected, the functional role and regulatory capacity of such transcripts have only been determined for individual cases. Long ncRNAs in general are reportedly able to regulate all steps of the gene expression process. Therefore, to get insight into the functionality of long ncRNAs transcribed bidirectionally from cancer-associated PCGs is of interest, as expression changes of tumor suppressor genes and oncogenes are prevalent in cancer.Here, we review the sources and characteristics of antisense transcription occurring at PCG loci in the human genome, and focus on the functional impact of bidirectional long ncRNA expression at cancer-associated PCGs.
© The Author 2015. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  antisense transcription; bidirectional promoter; cancer; long ncRNA

Mesh:

Substances:

Year:  2015        PMID: 26578749     DOI: 10.1093/bfgp/elv048

Source DB:  PubMed          Journal:  Brief Funct Genomics        ISSN: 2041-2649            Impact factor:   4.241


  10 in total

1.  LncRNAs and Available Databases.

Authors:  Sara Napoli
Journal:  Methods Mol Biol       Date:  2021

Review 2.  The Determinants of Directionality in Transcriptional Initiation.

Authors:  Dia N Bagchi; Vishwanath R Iyer
Journal:  Trends Genet       Date:  2016-04-07       Impact factor: 11.639

3.  Identification of a novel metastasis inducing lncRNA which suppresses the KAI1/CD82 metastasis suppressor gene and is upregulated in triple-negative breast cancer.

Authors:  Ronni Aram; Iris Dotan; Agnes Hotz-Wagenblatt; Dan Canaani
Journal:  Oncotarget       Date:  2017-06-28

4.  The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.

Authors:  Dong Ke; Hanwei Li; Yi Zhang; Yinghong An; Hanjiang Fu; Xuedong Fang; Xiaofei Zheng
Journal:  Oncotarget       Date:  2017-03-28

Review 5.  Challenges and Strategies in Ascribing Functions to Long Noncoding RNAs.

Authors:  Yang Zhao; Hongqi Teng; Fan Yao; Shannon Yap; Yutong Sun; Li Ma
Journal:  Cancers (Basel)       Date:  2020-06-03       Impact factor: 6.639

6.  Characterisation and functional predictions of canine long non-coding RNAs.

Authors:  Céline Le Béguec; Valentin Wucher; Lætitia Lagoutte; Edouard Cadieu; Nadine Botherel; Benoît Hédan; Clotilde De Brito; Anne-Sophie Guillory; Catherine André; Thomas Derrien; Christophe Hitte
Journal:  Sci Rep       Date:  2018-09-07       Impact factor: 4.379

Review 7.  Molecular mechanism of cell ferroptosis and research progress in regulation of ferroptosis by noncoding RNAs in tumor cells.

Authors:  Bumin Xie; Yuan Guo
Journal:  Cell Death Discov       Date:  2021-05-12

8.  Differential expression of long noncoding RNA in hepatocellular carcinoma on top of chronic HCV and HBV infections.

Authors:  Hany S Sabry; Safaa I Tayel; Mohamed E Enar; Naglaa S Elabd
Journal:  Clin Exp Hepatol       Date:  2021-12-08

Review 9.  Regulation of the Cancer Stem Phenotype by Long Non-Coding RNAs.

Authors:  Jose Adan Gutierrez-Cruz; Vilma Maldonado; Jorge Melendez-Zajgla
Journal:  Cells       Date:  2022-07-30       Impact factor: 7.666

Review 10.  Prospects of Noncoding RNAs in Hepatocellular Carcinoma.

Authors:  Huaixiang Zhou; Qiuran Xu; Chao Ni; Song Ye; Xiaowu Xu; Xiaoge Hu; Jiahong Jiang; Yeting Hong; Dongsheng Huang; Liu Yang
Journal:  Biomed Res Int       Date:  2018-07-26       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.